img

Global Cyclin Dependent Kinase 1 Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cyclin Dependent Kinase 1 Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Cyclin Dependent Kinase 1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Cyclin Dependent Kinase 1 is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Cyclin Dependent Kinase 1 is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Cyclin Dependent Kinase 1 is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Cyclin Dependent Kinase 1 include Astex Pharmaceuticals Inc, ChoDang Pharm Co Ltd, Presage Biosciences Inc, Tiziana Life Sciences Plc and Tragara Pharmaceuticals Inc, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Cyclin Dependent Kinase 1, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Cyclin Dependent Kinase 1 by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Cyclin Dependent Kinase 1 market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Cyclin Dependent Kinase 1 market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Astex Pharmaceuticals Inc
ChoDang Pharm Co Ltd
Presage Biosciences Inc
Tiziana Life Sciences Plc
Tragara Pharmaceuticals Inc
By Type
AT-7519
CD-650
Milciclib
Others
By Application
Relapsed Chronic Lymphocytic Leukemia
Gliosarcoma
Lymphoma
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Cyclin Dependent Kinase 1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Cyclin Dependent Kinase 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cyclin Dependent Kinase 1 sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Cyclin Dependent Kinase 1 Definition
1.2 Market by Type
1.2.1 Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 AT-7519
1.2.3 CD-650
1.2.4 Milciclib
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Relapsed Chronic Lymphocytic Leukemia
1.3.3 Gliosarcoma
1.3.4 Lymphoma
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Cyclin Dependent Kinase 1 Sales
2.1 Global Cyclin Dependent Kinase 1 Revenue Estimates and Forecasts 2018-2034
2.2 Global Cyclin Dependent Kinase 1 Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Cyclin Dependent Kinase 1 Revenue by Region
2.3.1 Global Cyclin Dependent Kinase 1 Revenue by Region (2018-2023)
2.3.2 Global Cyclin Dependent Kinase 1 Revenue by Region (2024-2034)
2.4 Global Cyclin Dependent Kinase 1 Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Cyclin Dependent Kinase 1 Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Cyclin Dependent Kinase 1 Sales Quantity by Region
2.6.1 Global Cyclin Dependent Kinase 1 Sales Quantity by Region (2018-2023)
2.6.2 Global Cyclin Dependent Kinase 1 Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Cyclin Dependent Kinase 1 Sales Quantity by Manufacturers
3.1.1 Global Cyclin Dependent Kinase 1 Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Cyclin Dependent Kinase 1 Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Cyclin Dependent Kinase 1 Sales in 2024
3.2 Global Cyclin Dependent Kinase 1 Revenue by Manufacturers
3.2.1 Global Cyclin Dependent Kinase 1 Revenue by Manufacturers (2018-2023)
3.2.2 Global Cyclin Dependent Kinase 1 Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Cyclin Dependent Kinase 1 Revenue in 2024
3.3 Global Cyclin Dependent Kinase 1 Sales Price by Manufacturers
3.4 Global Key Players of Cyclin Dependent Kinase 1, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cyclin Dependent Kinase 1, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cyclin Dependent Kinase 1, Product Offered and Application
3.8 Global Key Manufacturers of Cyclin Dependent Kinase 1, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Cyclin Dependent Kinase 1 Sales Quantity by Type
4.1.1 Global Cyclin Dependent Kinase 1 Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Cyclin Dependent Kinase 1 Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Cyclin Dependent Kinase 1 Sales Quantity Market Share by Type (2018-2034)
4.2 Global Cyclin Dependent Kinase 1 Revenue by Type
4.2.1 Global Cyclin Dependent Kinase 1 Historical Revenue by Type (2018-2023)
4.2.2 Global Cyclin Dependent Kinase 1 Forecasted Revenue by Type (2024-2034)
4.2.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2034)
4.3 Global Cyclin Dependent Kinase 1 Price by Type
4.3.1 Global Cyclin Dependent Kinase 1 Price by Type (2018-2023)
4.3.2 Global Cyclin Dependent Kinase 1 Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Cyclin Dependent Kinase 1 Sales Quantity by Application
5.1.1 Global Cyclin Dependent Kinase 1 Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Cyclin Dependent Kinase 1 Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Cyclin Dependent Kinase 1 Sales Quantity Market Share by Application (2018-2034)
5.2 Global Cyclin Dependent Kinase 1 Revenue by Application
5.2.1 Global Cyclin Dependent Kinase 1 Historical Revenue by Application (2018-2023)
5.2.2 Global Cyclin Dependent Kinase 1 Forecasted Revenue by Application (2024-2034)
5.2.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2034)
5.3 Global Cyclin Dependent Kinase 1 Price by Application
5.3.1 Global Cyclin Dependent Kinase 1 Price by Application (2018-2023)
5.3.2 Global Cyclin Dependent Kinase 1 Price Forecast by Application (2024-2034)
6 North America
6.1 North America Cyclin Dependent Kinase 1 Sales by Company
6.1.1 North America Cyclin Dependent Kinase 1 Revenue by Company (2018-2023)
6.1.2 North America Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023)
6.2 North America Cyclin Dependent Kinase 1 Market Size by Type
6.2.1 North America Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2034)
6.2.2 North America Cyclin Dependent Kinase 1 Revenue by Type (2018-2034)
6.3 North America Cyclin Dependent Kinase 1 Market Size by Application
6.3.1 North America Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2034)
6.3.2 North America Cyclin Dependent Kinase 1 Revenue by Application (2018-2034)
6.4 North America Cyclin Dependent Kinase 1 Market Size by Country
6.4.1 North America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Cyclin Dependent Kinase 1 Revenue by Country (2018-2034)
6.4.3 North America Cyclin Dependent Kinase 1 Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cyclin Dependent Kinase 1 Sales by Company
7.1.1 Europe Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023)
7.1.2 Europe Cyclin Dependent Kinase 1 Revenue by Company (2018-2023)
7.2 Europe Cyclin Dependent Kinase 1 Market Size by Type
7.2.1 Europe Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2034)
7.2.2 Europe Cyclin Dependent Kinase 1 Revenue by Type (2018-2034)
7.3 Europe Cyclin Dependent Kinase 1 Market Size by Application
7.3.1 Europe Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2034)
7.3.2 Europe Cyclin Dependent Kinase 1 Revenue by Application (2018-2034)
7.4 Europe Cyclin Dependent Kinase 1 Market Size by Country
7.4.1 Europe Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Cyclin Dependent Kinase 1 Revenue by Country (2018-2034)
7.4.3 Europe Cyclin Dependent Kinase 1 Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Cyclin Dependent Kinase 1 Sales by Company
8.1.1 China Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023)
8.1.2 China Cyclin Dependent Kinase 1 Revenue by Company (2018-2023)
8.2 China Cyclin Dependent Kinase 1 Market Size by Type
8.2.1 China Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2034)
8.2.2 China Cyclin Dependent Kinase 1 Revenue by Type (2018-2034)
8.3 China Cyclin Dependent Kinase 1 Market Size by Application
8.3.1 China Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2034)
8.3.2 China Cyclin Dependent Kinase 1 Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Cyclin Dependent Kinase 1 Sales by Company
9.1.1 APAC Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023)
9.1.2 APAC Cyclin Dependent Kinase 1 Revenue by Company (2018-2023)
9.2 APAC Cyclin Dependent Kinase 1 Market Size by Type
9.2.1 APAC Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2034)
9.2.2 APAC Cyclin Dependent Kinase 1 Revenue by Type (2018-2034)
9.3 APAC Cyclin Dependent Kinase 1 Market Size by Application
9.3.1 APAC Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2034)
9.3.2 APAC Cyclin Dependent Kinase 1 Revenue by Application (2018-2034)
9.4 APAC Cyclin Dependent Kinase 1 Market Size by Region
9.4.1 APAC Cyclin Dependent Kinase 1 Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Cyclin Dependent Kinase 1 Revenue by Region (2018-2034)
9.4.3 APAC Cyclin Dependent Kinase 1 Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales by Company
10.1.1 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Market Size by Type
10.2.1 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Market Size by Application
10.3.1 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Market Size by Country
10.4.1 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Astex Pharmaceuticals Inc
11.1.1 Astex Pharmaceuticals Inc Company Information
11.1.2 Astex Pharmaceuticals Inc Overview
11.1.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Products and Services
11.1.5 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 SWOT Analysis
11.1.6 Astex Pharmaceuticals Inc Recent Developments
11.2 ChoDang Pharm Co Ltd
11.2.1 ChoDang Pharm Co Ltd Company Information
11.2.2 ChoDang Pharm Co Ltd Overview
11.2.3 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Products and Services
11.2.5 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 SWOT Analysis
11.2.6 ChoDang Pharm Co Ltd Recent Developments
11.3 Presage Biosciences Inc
11.3.1 Presage Biosciences Inc Company Information
11.3.2 Presage Biosciences Inc Overview
11.3.3 Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Presage Biosciences Inc Cyclin Dependent Kinase 1 Products and Services
11.3.5 Presage Biosciences Inc Cyclin Dependent Kinase 1 SWOT Analysis
11.3.6 Presage Biosciences Inc Recent Developments
11.4 Tiziana Life Sciences Plc
11.4.1 Tiziana Life Sciences Plc Company Information
11.4.2 Tiziana Life Sciences Plc Overview
11.4.3 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Products and Services
11.4.5 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 SWOT Analysis
11.4.6 Tiziana Life Sciences Plc Recent Developments
11.5 Tragara Pharmaceuticals Inc
11.5.1 Tragara Pharmaceuticals Inc Company Information
11.5.2 Tragara Pharmaceuticals Inc Overview
11.5.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Products and Services
11.5.5 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 SWOT Analysis
11.5.6 Tragara Pharmaceuticals Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Cyclin Dependent Kinase 1 Value Chain Analysis
12.2 Cyclin Dependent Kinase 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cyclin Dependent Kinase 1 Production Mode & Process
12.4 Cyclin Dependent Kinase 1 Sales and Marketing
12.4.1 Cyclin Dependent Kinase 1 Sales Channels
12.4.2 Cyclin Dependent Kinase 1 Distributors
12.5 Cyclin Dependent Kinase 1 Customers
13 Market Dynamics
13.1 Cyclin Dependent Kinase 1 Industry Trends
13.2 Cyclin Dependent Kinase 1 Market Drivers
13.3 Cyclin Dependent Kinase 1 Market Challenges
13.4 Cyclin Dependent Kinase 1 Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of AT-7519
Table 3. Major Manufacturers of CD-650
Table 4. Major Manufacturers of Milciclib
Table 5. Major Manufacturers of Others
Table 6. Global Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Cyclin Dependent Kinase 1 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Cyclin Dependent Kinase 1 Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2018-2023)
Table 10. Global Cyclin Dependent Kinase 1 Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2024-2034)
Table 12. Global Cyclin Dependent Kinase 1 Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 13. Global Cyclin Dependent Kinase 1 Sales by Region (2018-2023) & (K Pcs)
Table 14. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2018-2023)
Table 15. Global Cyclin Dependent Kinase 1 Sales by Region (2024-2034) & (K Pcs)
Table 16. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2024-2034)
Table 17. Global Cyclin Dependent Kinase 1 Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 18. Global Cyclin Dependent Kinase 1 Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Cyclin Dependent Kinase 1 Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Cyclin Dependent Kinase 1 Revenue Share by Manufacturers (2018-2023)
Table 21. Global Cyclin Dependent Kinase 1 Price by Manufacturers 2018-2023 (USD/Pcs)
Table 22. Global Key Players of Cyclin Dependent Kinase 1, Industry Ranking, 2021 VS 2024
Table 23. Global Cyclin Dependent Kinase 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Cyclin Dependent Kinase 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclin Dependent Kinase 1 as of 2024)
Table 25. Global Key Manufacturers of Cyclin Dependent Kinase 1, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Cyclin Dependent Kinase 1, Product Offered and Application
Table 27. Global Key Manufacturers of Cyclin Dependent Kinase 1, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 30. Global Cyclin Dependent Kinase 1 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global Cyclin Dependent Kinase 1 Sales Quantity Share by Type (2018-2023)
Table 32. Global Cyclin Dependent Kinase 1 Sales Quantity Share by Type (2024-2034)
Table 33. Global Cyclin Dependent Kinase 1 Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Cyclin Dependent Kinase 1 Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Cyclin Dependent Kinase 1 Revenue Share by Type (2018-2023)
Table 36. Global Cyclin Dependent Kinase 1 Revenue Share by Type (2024-2034)
Table 37. Cyclin Dependent Kinase 1 Price by Type (2018-2023) & (USD/Pcs)
Table 38. Global Cyclin Dependent Kinase 1 Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 40. Global Cyclin Dependent Kinase 1 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global Cyclin Dependent Kinase 1 Sales Quantity Share by Application (2018-2023)
Table 42. Global Cyclin Dependent Kinase 1 Sales Quantity Share by Application (2024-2034)
Table 43. Global Cyclin Dependent Kinase 1 Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Cyclin Dependent Kinase 1 Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Cyclin Dependent Kinase 1 Revenue Share by Application (2018-2023)
Table 46. Global Cyclin Dependent Kinase 1 Revenue Share by Application (2024-2034)
Table 47. Cyclin Dependent Kinase 1 Price by Application (2018-2023) & (USD/Pcs)
Table 48. Global Cyclin Dependent Kinase 1 Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America Cyclin Dependent Kinase 1 Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 51. North America Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 52. North America Cyclin Dependent Kinase 1 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America Cyclin Dependent Kinase 1 Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Cyclin Dependent Kinase 1 Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 56. North America Cyclin Dependent Kinase 1 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America Cyclin Dependent Kinase 1 Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Cyclin Dependent Kinase 1 Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Cyclin Dependent Kinase 1 Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Cyclin Dependent Kinase 1 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 63. North America Cyclin Dependent Kinase 1 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 65. Europe Cyclin Dependent Kinase 1 Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 67. Europe Cyclin Dependent Kinase 1 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe Cyclin Dependent Kinase 1 Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Cyclin Dependent Kinase 1 Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 71. Europe Cyclin Dependent Kinase 1 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe Cyclin Dependent Kinase 1 Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Cyclin Dependent Kinase 1 Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Cyclin Dependent Kinase 1 Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Cyclin Dependent Kinase 1 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 78. Europe Cyclin Dependent Kinase 1 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 80. China Cyclin Dependent Kinase 1 Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 82. China Cyclin Dependent Kinase 1 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China Cyclin Dependent Kinase 1 Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Cyclin Dependent Kinase 1 Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 86. China Cyclin Dependent Kinase 1 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China Cyclin Dependent Kinase 1 Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Cyclin Dependent Kinase 1 Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 90. APAC Cyclin Dependent Kinase 1 Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 92. APAC Cyclin Dependent Kinase 1 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC Cyclin Dependent Kinase 1 Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Cyclin Dependent Kinase 1 Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 96. APAC Cyclin Dependent Kinase 1 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC Cyclin Dependent Kinase 1 Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Cyclin Dependent Kinase 1 Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Cyclin Dependent Kinase 1 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Cyclin Dependent Kinase 1 Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Cyclin Dependent Kinase 1 Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Cyclin Dependent Kinase 1 Sales Quantity by Region (2018-2023) & (K Pcs)
Table 103. APAC Cyclin Dependent Kinase 1 Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 105. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 111. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 118. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Astex Pharmaceuticals Inc Company Information
Table 120. Astex Pharmaceuticals Inc Description and Overview
Table 121. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product and Services
Table 123. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 SWOT Analysis
Table 124. Astex Pharmaceuticals Inc Recent Developments
Table 125. ChoDang Pharm Co Ltd Company Information
Table 126. ChoDang Pharm Co Ltd Description and Overview
Table 127. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 128. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product and Services
Table 129. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 SWOT Analysis
Table 130. ChoDang Pharm Co Ltd Recent Developments
Table 131. Presage Biosciences Inc Company Information
Table 132. Presage Biosciences Inc Description and Overview
Table 133. Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 134. Presage Biosciences Inc Cyclin Dependent Kinase 1 Product and Services
Table 135. Presage Biosciences Inc Cyclin Dependent Kinase 1 SWOT Analysis
Table 136. Presage Biosciences Inc Recent Developments
Table 137. Tiziana Life Sciences Plc Company Information
Table 138. Tiziana Life Sciences Plc Description and Overview
Table 139. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product and Services
Table 141. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 SWOT Analysis
Table 142. Tiziana Life Sciences Plc Recent Developments
Table 143. Tragara Pharmaceuticals Inc Company Information
Table 144. Tragara Pharmaceuticals Inc Description and Overview
Table 145. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 146. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product and Services
Table 147. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 SWOT Analysis
Table 148. Tragara Pharmaceuticals Inc Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Cyclin Dependent Kinase 1 Distributors List
Table 152. Cyclin Dependent Kinase 1 Customers List
Table 153. Cyclin Dependent Kinase 1 Market Trends
Table 154. Cyclin Dependent Kinase 1 Market Drivers
Table 155. Cyclin Dependent Kinase 1 Market Challenges
Table 156. Cyclin Dependent Kinase 1 Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyclin Dependent Kinase 1 Product Picture
Figure 2. Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Cyclin Dependent Kinase 1 Market Share by Type in 2024 & 2034
Figure 4. AT-7519 Product Picture
Figure 5. CD-650 Product Picture
Figure 6. Milciclib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Cyclin Dependent Kinase 1 Market Share by Application in 2024 & 2034
Figure 10. Relapsed Chronic Lymphocytic Leukemia
Figure 11. Gliosarcoma
Figure 12. Lymphoma
Figure 13. Others
Figure 14. Cyclin Dependent Kinase 1 Report Years Considered
Figure 15. Global Cyclin Dependent Kinase 1 Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Cyclin Dependent Kinase 1 Revenue 2018-2034 (US$ Million)
Figure 17. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Cyclin Dependent Kinase 1 Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Cyclin Dependent Kinase 1 Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Cyclin Dependent Kinase 1 Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Cyclin Dependent Kinase 1 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Cyclin Dependent Kinase 1 Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Cyclin Dependent Kinase 1 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Cyclin Dependent Kinase 1 Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Cyclin Dependent Kinase 1 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Cyclin Dependent Kinase 1 Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Cyclin Dependent Kinase 1 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Cyclin Dependent Kinase 1 Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Cyclin Dependent Kinase 1 Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Cyclin Dependent Kinase 1 Revenue in 2024
Figure 33. Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Cyclin Dependent Kinase 1 Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2034)
Figure 36. Global Cyclin Dependent Kinase 1 Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2034)
Figure 38. North America Cyclin Dependent Kinase 1 Revenue Market Share by Company in 2024
Figure 39. North America Cyclin Dependent Kinase 1 Sales Quantity Market Share by Company in 2024
Figure 40. North America Cyclin Dependent Kinase 1 Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2034)
Figure 42. North America Cyclin Dependent Kinase 1 Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2034)
Figure 44. North America Cyclin Dependent Kinase 1 Revenue Share by Country (2018-2034)
Figure 45. North America Cyclin Dependent Kinase 1 Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Cyclin Dependent Kinase 1 Sales Quantity Market Share by Company in 2024
Figure 49. Europe Cyclin Dependent Kinase 1 Revenue Market Share by Company in 2024
Figure 50. Europe Cyclin Dependent Kinase 1 Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2034)
Figure 52. Europe Cyclin Dependent Kinase 1 Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2034)
Figure 54. Europe Cyclin Dependent Kinase 1 Revenue Share by Country (2018-2034)
Figure 55. Europe Cyclin Dependent Kinase 1 Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 57. France Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 61. China Cyclin Dependent Kinase 1 Sales Quantity Market Share by Company in 2024
Figure 62. China Cyclin Dependent Kinase 1 Revenue Market Share by Company in 2024
Figure 63. China Cyclin Dependent Kinase 1 Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2034)
Figure 65. China Cyclin Dependent Kinase 1 Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2034)
Figure 67. APAC Cyclin Dependent Kinase 1 Sales Quantity Market Share by Company in 2024
Figure 68. APAC Cyclin Dependent Kinase 1 Revenue Market Share by Company in 2024
Figure 69. APAC Cyclin Dependent Kinase 1 Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2034)
Figure 71. APAC Cyclin Dependent Kinase 1 Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2034)
Figure 73. APAC Cyclin Dependent Kinase 1 Revenue Share by Region (2018-2034)
Figure 74. APAC Cyclin Dependent Kinase 1 Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 79. India Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Cyclin Dependent Kinase 1 Revenue Share by Country (2018-2034)
Figure 88. Brazil Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Cyclin Dependent Kinase 1 Revenue (2018-2034) & (US$ Million)
Figure 93. Cyclin Dependent Kinase 1 Value Chain
Figure 94. Cyclin Dependent Kinase 1 Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed